- Home
- SHBI vs CELC Comparison
SHBI vs CELC Comparison
Compare SHBI & CELC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHBI
- CELC
- Stock Information
- Founded
- SHBI 1876
- CELC 2011
- Country
- SHBI United States
- CELC United States
- Employees
- SHBI N/A
- CELC N/A
- Industry
- SHBI Major Banks
- CELC Medical Specialities
- Sector
- SHBI Finance
- CELC Health Care
- Exchange
- SHBI Nasdaq
- CELC Nasdaq
- Market Cap
- SHBI 545.9M
- CELC 594.7M
- IPO Year
- SHBI N/A
- CELC 2017
- Fundamental
- Price
- SHBI $16.25
- CELC $12.72
- Analyst Decision
- SHBI Hold
- CELC Strong Buy
- Analyst Count
- SHBI 2
- CELC 6
- Target Price
- SHBI $15.00
- CELC $29.17
- AVG Volume (30 Days)
- SHBI 99.6K
- CELC 272.6K
- Earning Date
- SHBI 10-24-2024
- CELC 11-14-2024
- Dividend Yield
- SHBI 3.00%
- CELC N/A
- EPS Growth
- SHBI 215.95
- CELC N/A
- EPS
- SHBI 1.23
- CELC N/A
- Revenue
- SHBI $193,048,000.00
- CELC N/A
- Revenue This Year
- SHBI N/A
- CELC N/A
- Revenue Next Year
- SHBI $7.23
- CELC N/A
- P/E Ratio
- SHBI $12.98
- CELC N/A
- Revenue Growth
- SHBI 71.02
- CELC N/A
- 52 Week Low
- SHBI $10.06
- CELC $11.51
- 52 Week High
- SHBI $16.66
- CELC $22.19
- Technical
- Relative Strength Index (RSI)
- SHBI 64.89
- CELC 31.15
- Support Level
- SHBI $15.10
- CELC $12.08
- Resistance Level
- SHBI $16.50
- CELC $13.04
- Average True Range (ATR)
- SHBI 0.45
- CELC 0.88
- MACD
- SHBI -0.01
- CELC -0.28
- Stochastic Oscillator
- SHBI 80.16
- CELC 24.04
About SHBI Shore Bancshares Inc
Shore Bancshares Inc is a financial holding company. It offers personalized banking, insurance, and investment services to families and businesses in the Mid-Atlantic region. It operates in two business segments - community banking and mortgage banking. Community banking is conducted through the Bank and involves delivering a broad range of financial services, including lending and deposit-taking, to individuals and commercial enterprises, it also includes treasury and administrative functions. Mortgage banking is conducted through the Bank's secondary marketing department and involves originating first and second-lien residential mortgages for sale in the secondary market.
About CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are highly differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.